Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Targets of Arsenic Trioxide in Malignant Cells

1 Apr 2002

Abstract excerpt

Abstract Learning Objectives After taking all of the CME courses in this supplement the reader will be able to: Describe the basic biology of various leukemias, multiple myeloma, and myelodysplastic syndrome (MDS).Discuss new targeted treatment strategies for hematologic malignancies.Understand the rationale for the use of nontraditional cytotoxic agents such as arsenic trioxide in the treatment of hematologic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antioxidant Activity and Oxidative Stress
Share to Estrogen and related hormone effects
Share to Retinoids in leukemia and cellular processes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11961205
DOI: 10.1634/theoncologist.7-suppl_1-14

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Targets of Arsenic Trioxide in Malignant CellsPMID 11961205Read ↗

Arsenic-Based Antineoplastic Drugs and Their Mechanisms of ActionSemantic proximity Read ↗

Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemiaSemantic proximity Read ↗

Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.Semantic proximity Read ↗

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.Semantic proximity Read ↗

Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcriptionSemantic proximity Read ↗

Treatment of acute promyelocytic leukaemia with <i>all-trans</i> retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapySemantic proximity Read ↗

Arsenic trioxide selectively induces early and extensive apoptosis via the APO2/caspase-8 pathway engaging the mitochondrial pathway in myeloma cells with mutant p53.Semantic proximity Read ↗

Acute promyelocytic leukemia: from highly fatal to highly curableSemantic proximity Read ↗

Dual effects of arsenic trioxide (As2O3) on non‐acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferationSemantic proximity Read ↗

Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia.Semantic proximity Read ↗

Arsenic trioxide promotes mitochondrial DNA mutation and cell apoptosis in primary APL cells and NB4 cell line.Semantic proximity Read ↗

Treatment of Acute Promyelocytic LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.